Page last updated: 2024-08-25

lotrafiban and Myocardial Ischemia

lotrafiban has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amarenco, P; Califf, R; Chan, R; Davis, S; Diener, HC; Easton, JD; Ferguson, J; Fitzgerald, D; Graffagnino, C; Granett, J; Harrington, R; Ilson, B; Koudstaal, PJ; Samuels, R; Shuaib, A; Theroux, P; Topol, EJ; Van de Werf, F; Willerson, JT	1

Trials

1 trial(s) available for lotrafiban and Myocardial Ischemia

Article	Year
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. American heart journal, 2000, Volume: 139, Issue:6 Topics: Administration, Oral; Adolescent; Arterial Occlusive Diseases; Benzodiazepines; Double-Blind Method; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Secondary Prevention; Stroke	2000

Article

Year

Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

American heart journal, 2000, Volume: 139, Issue:6

Topics: Administration, Oral; Adolescent; Arterial Occlusive Diseases; Benzodiazepines; Double-Blind Method; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Secondary Prevention; Stroke

2000